This map shows the geographic impact of W Rupp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Rupp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Rupp more than expected).
This network shows the impact of papers produced by W Rupp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Rupp. The network helps show where W Rupp may publish in the future.
Co-authorship network of co-authors of W Rupp
This figure shows the co-authorship network connecting the top 25 collaborators of W Rupp.
A scholar is included among the top collaborators of W Rupp based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with W Rupp. W Rupp is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Frölich, J. C., et al.. (1986). The effects of metamizol on prostaglandin synthesis in man.. PubMed. 19. 155–66.9 indexed citations
7.
Rupp, W, et al.. (1985). [Pharmacokinetics and metabolism of Articain after intramuscular injection in a male subject].. PubMed. 8(1). 67–71.1 indexed citations
Arnold, Carolyn E., et al.. (1981). [Pharmacokinetics and biotransformation of the antimycotic drug ciclopiroxolamine in animals and man after topical and systemic administration].. PubMed. 31(8A). 1337–53.21 indexed citations
10.
Rupp, W. (1980). Some aspects of the clinical pharmacology of furosemide.. PubMed. Suppl. 119–29.4 indexed citations
11.
Taeuber, Karl E., et al.. (1979). Pharmacodynamic comparison of the acute effects of nomifensine, amphetamine and placebo in healthy volunteers.. PubMed. 17(1). 32–7.22 indexed citations
12.
Rupp, W, et al.. (1973). [Examples of phase I: diuretics].. PubMed. 23(11). Suppl:1665–8.7 indexed citations
13.
Christ, O, et al.. (1972). [Pharmacokinetic studies following oral administration of 3,7-dimethyl-1-(5-oxo-hexyl)xanthine- 14 C (BL 191- 14 C) in rats, dogs and man].. PubMed. 22(11). 1933–7.7 indexed citations
14.
Heidland, A., H. Hennemann, A Röckel, & W Rupp. (1971). [Clinical pharmacology of high-dose furosemide in terminal renal insufficiency].. PubMed. 56(5). 620–9.1 indexed citations
Heptner, W., et al.. (1969). [Pharmacokinetics of a new highly effective hypoglycemic sulfonylurea derivative].. PubMed. 6 Suppl 1. 105–15.5 indexed citations
17.
Rupp, W. (1959). [Urinary excretion of leukocytes & bacteria in normal children; determination by quantitative methods].. PubMed. 14(7). 132–4.3 indexed citations
Rupp, W. (1955). [Analysis of phosphoric acid esters with radiophosphorus and paper iontophoresis].. PubMed. 10(1-2). 111–4.1 indexed citations
20.
Rupp, W, et al.. (1955). [Research on phosphoric acid esters with radioactive phosphorus and paper electrophoresis].. PubMed. 150(3). 221–6.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.